Know Cancer

or
forgot password

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors


Phase 2
18 Years
N/A
Not Enrolling
Female
Ovarian Cancer

Thank you

Trial Information

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors


Inclusion Criteria:



- Patient aged over 18 years

- Ovarian cancer patients with at least five tumor samples does not affect the
diagnosis, based on other tumor masses

- Surgery of any initial chemotherapy naive

- Patient information and signed informed consent

Exclusion Criteria:

- A person deprived of liberty or under guardianship

- Insufficient tumor samples of ovarian cancer.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

rate of apoptotic cells

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

JOLY Florence, Pr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre françois Baclesse

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

ABT-737 ex vivo

NCT ID:

NCT01440504

Start Date:

April 2010

Completion Date:

January 2013

Related Keywords:

  • Ovarian Cancer
  • Cancer
  • Ovarian
  • chemotherapy
  • BH3-mimetic
  • platin
  • ex-vivo
  • Ovarian Neoplasms

Name

Location